Chemotherapy of Experimental Anthrax Infections

Chemotherapy of Experimental Anthrax Infections

Streptomycin, penicillin and sodium sulfadiazine were tested for efficacy in experimental anthrax infections in mice. Maximal survival rates of 92 per cent were obtained with streptomycin, 58 per cent with penicillin, and only 5 per cent with sulfadiazine. Latent infections were not present in treat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of immunology (1950) 1946-08, Vol.53 (4), p.371-379
Hauptverfasser: Miller, Edward S, Scott, Earl B, Noe, Herbert A, Madin, Stewart H, Henley, Thomas F
Format: Artikel
Sprache:eng
Schlagworte:
Anthrax - therapy
Humans
Old Medline
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 379
container_issue 4
container_start_page 371
container_title The Journal of immunology (1950)
container_volume 53
creator Miller, Edward S
Scott, Earl B
Noe, Herbert A
Madin, Stewart H
Henley, Thomas F
description Streptomycin, penicillin and sodium sulfadiazine were tested for efficacy in experimental anthrax infections in mice. Maximal survival rates of 92 per cent were obtained with streptomycin, 58 per cent with penicillin, and only 5 per cent with sulfadiazine. Latent infections were not present in treated animals surviving 28 days after inoculation with lethal doses of B. anthracis spores.
doi_str_mv 10.4049/jimmunol.53.4.371
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_761320021</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>761320021</sourcerecordid><originalsourceid>FETCH-LOGICAL-c330t-cb4bf2d1bae39400e6602147bbd10864a8613f7d2c6d4a743057995ca9c643673</originalsourceid><addsrcrecordid>eNo9kDtPwzAUhS0EoqXwA1hQFsSU9PoROxmrqkClSiwwW47jkFR5YSdK--8xKu10l-8cnfsh9IghYsDS5b5qmrHt6iimEYuowFdojuMYQs6BX6M5ACEhFlzM0J1zewDgQNgtmhFI0yQhMEfLdWmabiiNVf0x6Ipgc-iNrRrTDqoOVu1QWnUItm1h9FB1rbtHN4WqnXn4vwv09br5XL-Hu4-37Xq1CzWlMIQ6Y1lBcpwpQ1MGYPwigpnIshxDwplKOKaFyInmOVOCUYhFmsZapZozygVdoJdTb2-7n9G4QTaV06auVWu60Unh88T_hz2JT6S2nXPWFLL3-5U9SgzyT5M8a5IxlUx6TT7z9N8-Zo3JL4mzFw88n4Cy-i6nyhrpGlXXHsdymqZL0S_hqHF1</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>761320021</pqid></control><display><type>article</type><title>Chemotherapy of Experimental Anthrax Infections</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Miller, Edward S ; Scott, Earl B ; Noe, Herbert A ; Madin, Stewart H ; Henley, Thomas F</creator><creatorcontrib>Miller, Edward S ; Scott, Earl B ; Noe, Herbert A ; Madin, Stewart H ; Henley, Thomas F</creatorcontrib><description>Streptomycin, penicillin and sodium sulfadiazine were tested for efficacy in experimental anthrax infections in mice. Maximal survival rates of 92 per cent were obtained with streptomycin, 58 per cent with penicillin, and only 5 per cent with sulfadiazine. Latent infections were not present in treated animals surviving 28 days after inoculation with lethal doses of B. anthracis spores.</description><identifier>ISSN: 0022-1767</identifier><identifier>EISSN: 1550-6606</identifier><identifier>DOI: 10.4049/jimmunol.53.4.371</identifier><identifier>PMID: 20998820</identifier><language>eng</language><publisher>United States: Am Assoc Immnol</publisher><subject>Anthrax - therapy ; Humans ; Old Medline</subject><ispartof>The Journal of immunology (1950), 1946-08, Vol.53 (4), p.371-379</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c330t-cb4bf2d1bae39400e6602147bbd10864a8613f7d2c6d4a743057995ca9c643673</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20998820$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Miller, Edward S</creatorcontrib><creatorcontrib>Scott, Earl B</creatorcontrib><creatorcontrib>Noe, Herbert A</creatorcontrib><creatorcontrib>Madin, Stewart H</creatorcontrib><creatorcontrib>Henley, Thomas F</creatorcontrib><title>Chemotherapy of Experimental Anthrax Infections</title><title>The Journal of immunology (1950)</title><addtitle>J Immunol</addtitle><description>Streptomycin, penicillin and sodium sulfadiazine were tested for efficacy in experimental anthrax infections in mice. Maximal survival rates of 92 per cent were obtained with streptomycin, 58 per cent with penicillin, and only 5 per cent with sulfadiazine. Latent infections were not present in treated animals surviving 28 days after inoculation with lethal doses of B. anthracis spores.</description><subject>Anthrax - therapy</subject><subject>Humans</subject><subject>Old Medline</subject><issn>0022-1767</issn><issn>1550-6606</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1946</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kDtPwzAUhS0EoqXwA1hQFsSU9PoROxmrqkClSiwwW47jkFR5YSdK--8xKu10l-8cnfsh9IghYsDS5b5qmrHt6iimEYuowFdojuMYQs6BX6M5ACEhFlzM0J1zewDgQNgtmhFI0yQhMEfLdWmabiiNVf0x6Ipgc-iNrRrTDqoOVu1QWnUItm1h9FB1rbtHN4WqnXn4vwv09br5XL-Hu4-37Xq1CzWlMIQ6Y1lBcpwpQ1MGYPwigpnIshxDwplKOKaFyInmOVOCUYhFmsZapZozygVdoJdTb2-7n9G4QTaV06auVWu60Unh88T_hz2JT6S2nXPWFLL3-5U9SgzyT5M8a5IxlUx6TT7z9N8-Zo3JL4mzFw88n4Cy-i6nyhrpGlXXHsdymqZL0S_hqHF1</recordid><startdate>194608</startdate><enddate>194608</enddate><creator>Miller, Edward S</creator><creator>Scott, Earl B</creator><creator>Noe, Herbert A</creator><creator>Madin, Stewart H</creator><creator>Henley, Thomas F</creator><general>Am Assoc Immnol</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>194608</creationdate><title>Chemotherapy of Experimental Anthrax Infections</title><author>Miller, Edward S ; Scott, Earl B ; Noe, Herbert A ; Madin, Stewart H ; Henley, Thomas F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c330t-cb4bf2d1bae39400e6602147bbd10864a8613f7d2c6d4a743057995ca9c643673</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1946</creationdate><topic>Anthrax - therapy</topic><topic>Humans</topic><topic>Old Medline</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Miller, Edward S</creatorcontrib><creatorcontrib>Scott, Earl B</creatorcontrib><creatorcontrib>Noe, Herbert A</creatorcontrib><creatorcontrib>Madin, Stewart H</creatorcontrib><creatorcontrib>Henley, Thomas F</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of immunology (1950)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Miller, Edward S</au><au>Scott, Earl B</au><au>Noe, Herbert A</au><au>Madin, Stewart H</au><au>Henley, Thomas F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Chemotherapy of Experimental Anthrax Infections</atitle><jtitle>The Journal of immunology (1950)</jtitle><addtitle>J Immunol</addtitle><date>1946-08</date><risdate>1946</risdate><volume>53</volume><issue>4</issue><spage>371</spage><epage>379</epage><pages>371-379</pages><issn>0022-1767</issn><eissn>1550-6606</eissn><abstract>Streptomycin, penicillin and sodium sulfadiazine were tested for efficacy in experimental anthrax infections in mice. Maximal survival rates of 92 per cent were obtained with streptomycin, 58 per cent with penicillin, and only 5 per cent with sulfadiazine. Latent infections were not present in treated animals surviving 28 days after inoculation with lethal doses of B. anthracis spores.</abstract><cop>United States</cop><pub>Am Assoc Immnol</pub><pmid>20998820</pmid><doi>10.4049/jimmunol.53.4.371</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-1767
ispartof The Journal of immunology (1950), 1946-08, Vol.53 (4), p.371-379
issn 0022-1767
1550-6606
language eng
recordid cdi_proquest_miscellaneous_761320021
source MEDLINE; Alma/SFX Local Collection
subjects Anthrax - therapy
Humans
Old Medline
title Chemotherapy of Experimental Anthrax Infections
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T20%3A21%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Chemotherapy%20of%20Experimental%20Anthrax%20Infections&rft.jtitle=The%20Journal%20of%20immunology%20(1950)&rft.au=Miller,%20Edward%20S&rft.date=1946-08&rft.volume=53&rft.issue=4&rft.spage=371&rft.epage=379&rft.pages=371-379&rft.issn=0022-1767&rft.eissn=1550-6606&rft_id=info:doi/10.4049/jimmunol.53.4.371&rft_dat=%3Cproquest_cross%3E761320021%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=761320021&rft_id=info:pmid/20998820&rfr_iscdi=true